Enhancing chemotherapy sensitivity by targeting PcG via the ATM/p53 pathway.

Shu-Bin Gao(Xiamen University), Lixiang Xue(Peking University), Yue Zhao(University Hospital Cologne), Shi Shu(Peking University), Guang‐Hui Jin(Xiamen University), Huan Qiu(Anhui Medical University), Shuhua Wei(Peking University), Ling-Yu Zhu(Xiamen University), Chang-Bao Pan(Xiamen University), Kang‐Li Li(Guangzhou Medical University)
PubMed
January 1, 2017
Cited by 18

Related Papers

Resistance to neoadjuvant chemotherapy in triple-negative breast cancer mediated by a reversible drug-tolerant state
|Science Translational Medicine|2019|316
Insights into the red algae and eukaryotic evolution from the genome of <i>Porphyra umbilicalis</i> (Bangiophyceae, Rhodophyta)
|Proceedings of the National Academy of Sciences|2017|309
Comparative genomics explains the evolutionary success of reef-forming corals
|eLife|2016|213
High-resolution clonal mapping of multi-organ metastasis in triple negative breast cancer
|Nature Communications|2018|149
IL-7: A promising adjuvant ensuring effective T cell responses and memory in combination with cancer vaccines?
|Frontiers in Immunology|2022|72